Skip to main content
. 2022 Jun 7;29(9):2744–2753. doi: 10.1111/ene.15412

TABLE 2.

Treatment discontinuation at 18 months (N = 1138)

Outcome, n (%)
Treatment discontinuation 633 (55.6)
Reason for discontinuation (n = 588 a )
Ineffectiveness 374 (63.6)
Adverse event(s) 179 (30.4)
Other 35 (6.0)
Subjects (with no missed visits) maintaining treatment over time
Baseline 1138 (100.0)
4 weeks 1138 (100.0)
3 months 760 (66.8)
6 months 653 (57.4)
12 months 473 (41.6)
18 months 397 (34.9)

Abbreviations: N, number of patients.

a

Reasons for discontinuation were not recorded (missing/unknown) for 45 (7.1%) discontinued cases.